title: Should we screen for prostate cancer? A re-examination of the evidence.
authors.affiliation: Bond University, Gold Coast, QLD. cdelmar@bond.edu.au
authors.forename: Chris B
authors.initials: CB
authors.lastname: Del Mar
authors.forename: Paul P
authors.initials: PP
authors.lastname: Glasziou
authors.forename: Geoffrey H
authors.initials: GH
authors.lastname: Hirst
authors.forename: Robert G
authors.initials: RG
authors.lastname: Wright
authors.forename: Tammy C
authors.initials: TC
authors.lastname: Hoffmann
mesh_terms: D015415:Biomarkers / Q000097:blood; D003661:Decision Support Techniques; D055088:Early Detection of Cancer / Q000009:adverse effects / Q000379:methods; D006801:Humans; D007610:Kallikreins / Q000097:blood*; D008297:Male; D010358:Patient Participation; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis*; D018570:Risk Assessment; D019564:Unnecessary Procedures
chemical_list: D015415:Biomarkers; C549870:KLK3 protein, human; D007610:Kallikreins; D017430:Prostate-Specific Antigen